Safety of cangrelor and transition to oral P2Y(12) inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study

por De Luca, Leonardo, Calabrò, Paolo, Capranzano, Piera, Di Mario, Carlo, Chirillo, Fabio, Rolfo, Cristina, Menozzi, Alberto, Menichelli, Maurizio, Bolognese, Leonardo, Musumeci, Giuseppe
Publicado 2023

Clinical Outcomes of Percutaneous Left-Atrial Appendage Occlusion with Conscious Sedation without an Anesthesiologist on Site: Results from a Multicenter Study

por Bianco, Matteo, Visalli, Andrea Carmelo, Tomassini, Francesco, Biolè, Carloalberto, Giacobbe, Federico, Rolfo, Cristina, Cerrato, Enrico, Franzè, Alfonso, Zanda, Greca, Pavani, Marco, Mousavi, Amir Hassan, Gobello, Giulia, Piedimonte, Giulio, Destefanis, Paola, Lazzero, Maurizio, Palacio Restrepo, Sara, Celentani, Dario, Luciano, Alessia, Tizzani, Emanuele, Chinaglia, Alessandra, Varbella, Ferdinando
Publicado 2023

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

por De Luca, Leonardo, Calabrò, Paolo, Chirillo, Fabio, Rolfo, Cristina, Menozzi, Alberto, Capranzano, Piera, Menichelli, Maurizio, Nicolini, Elisa, Mauro, Ciro, Trani, Carlo, Versaci, Francesco, Tomai, Fabrizio, Musumeci, Giuseppe, Di Mario, Carlo, Pepe, Martino, Berti, Sergio, Cernetti, Carlo, Cirillo, Plinio, Maffeo, Diego, Talanas, Giuseppe, Ferlini, Marco, Contarini, Marco, Lanzilotti, Valerio, Scherillo, Marino, Tarantini, Giuseppe, Muraglia, Simone, Rossini, Roberta, Bolognese, Leonardo
Publicado 2022